You just read:

Regeneron and Sanofi Announce Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia in the European Union

News provided by

Regeneron Pharmaceuticals, Inc.

Sep 28, 2015, 01:00 ET